JP2023533693A5 - - Google Patents

Info

Publication number
JP2023533693A5
JP2023533693A5 JP2022580238A JP2022580238A JP2023533693A5 JP 2023533693 A5 JP2023533693 A5 JP 2023533693A5 JP 2022580238 A JP2022580238 A JP 2022580238A JP 2022580238 A JP2022580238 A JP 2022580238A JP 2023533693 A5 JP2023533693 A5 JP 2023533693A5
Authority
JP
Japan
Prior art keywords
xyl
rha
fuc
glc
saponin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022580238A
Other languages
English (en)
Japanese (ja)
Other versions
JP7862331B2 (ja
JP2023533693A (ja
Filing date
Publication date
Priority claimed from PCT/NL2021/050384 external-priority patent/WO2021261992A1/en
Application filed filed Critical
Priority claimed from PCT/NL2021/050394 external-priority patent/WO2021261998A1/en
Publication of JP2023533693A publication Critical patent/JP2023533693A/ja
Publication of JP2023533693A5 publication Critical patent/JP2023533693A5/ja
Priority to JP2026073994A priority Critical patent/JP2026126321A/ja
Application granted granted Critical
Publication of JP7862331B2 publication Critical patent/JP7862331B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022580238A 2020-06-24 2021-06-23 GalNAc-オリゴヌクレオチドコンジュゲート及びサポニンの治療用配合物、及びその使用 Active JP7862331B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026073994A JP2026126321A (ja) 2020-06-24 2026-04-27 GalNAc-オリゴヌクレオチドコンジュゲート及びサポニンの治療用配合物、及びその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
NL2025902 2020-06-24
NL2025902 2020-06-24
PCT/NL2021/050384 WO2021261992A1 (en) 2020-06-24 2021-06-18 Conjugate of galnac and saponin, therapeutic composition comprising said conjugate and a galnac-oligonucleotide conjugate
NLPCT/NL2021/050384 2021-06-18
PCT/NL2021/050394 WO2021261998A1 (en) 2020-06-24 2021-06-23 Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026073994A Division JP2026126321A (ja) 2020-06-24 2026-04-27 GalNAc-オリゴヌクレオチドコンジュゲート及びサポニンの治療用配合物、及びその使用

Publications (3)

Publication Number Publication Date
JP2023533693A JP2023533693A (ja) 2023-08-04
JP2023533693A5 true JP2023533693A5 (cg-RX-API-DMAC10.html) 2024-07-01
JP7862331B2 JP7862331B2 (ja) 2026-05-19

Family

ID=72087123

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022580238A Active JP7862331B2 (ja) 2020-06-24 2021-06-23 GalNAc-オリゴヌクレオチドコンジュゲート及びサポニンの治療用配合物、及びその使用
JP2026073994A Pending JP2026126321A (ja) 2020-06-24 2026-04-27 GalNAc-オリゴヌクレオチドコンジュゲート及びサポニンの治療用配合物、及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026073994A Pending JP2026126321A (ja) 2020-06-24 2026-04-27 GalNAc-オリゴヌクレオチドコンジュゲート及びサポニンの治療用配合物、及びその使用

Country Status (6)

Country Link
US (1) US20230293562A1 (cg-RX-API-DMAC10.html)
EP (2) EP4596052A3 (cg-RX-API-DMAC10.html)
JP (2) JP7862331B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230044196A (cg-RX-API-DMAC10.html)
CN (1) CN116194148A (cg-RX-API-DMAC10.html)
IL (1) IL299349A (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026060043A1 (en) * 2024-09-10 2026-03-19 Xact Bio, Inc. Compositions and methods for targeting a tissue specific protein expression

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2522213A1 (en) * 2003-04-08 2004-10-28 Dante J. Marciani Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines
WO2011054811A1 (en) * 2009-11-03 2011-05-12 Santaris Pharma A/S Rna antagonists targeting hsp27 combination therapy
KR20160083876A (ko) * 2013-11-14 2016-07-12 로슈 이노베이션 센터 코펜하겐 에이/에스 ApoB 안티센스 접합체 화합물
US20220023433A1 (en) * 2018-12-21 2022-01-27 Sapreme Technologies B.V. Saponin Conjugates

Similar Documents

Publication Publication Date Title
EP4355369B1 (en) Conjugate of saponin, oligonucleotide and galnac
JPH10501237A (ja) オリゴヌクレオチドのためのシクロデキストリン細胞送達系
US20070060499A1 (en) Chloroquine combination drugs and methods for their synthesis
JP2023532040A5 (cg-RX-API-DMAC10.html)
JP2022546055A5 (cg-RX-API-DMAC10.html)
AU2013262415B2 (en) Oligonucleotide chelate complex methods
CN113454221A (zh) 含有三元环的双链核酸抑制剂分子
TW202113081A (zh) 用於治療α-1抗胰蛋白酶缺乏症(AATD)的方法
CA3183881A1 (en) Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof
JP2023532681A5 (cg-RX-API-DMAC10.html)
JP2022542075A5 (cg-RX-API-DMAC10.html)
WO2023208109A1 (zh) 用于抑制HSD17B13表达的siRNA、其缀合物和药物组合物及其用途
US20060040879A1 (en) Chloroquine coupled nucleic acids and methods for their synthesis
JP2023542500A5 (cg-RX-API-DMAC10.html)
TW202237189A (zh) 具有增強之肝靶向的s抗原運輸抑制寡核苷酸聚合物之接合物
JP2023532679A5 (cg-RX-API-DMAC10.html)
EP4171643B1 (en) Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof
CN118512601A (zh) 双链核酸-半乳糖胺-胆固醇化合物及其应用
EP4210760B1 (en) Conjugate of saponin, oligonucleotide and galnac
WO2006123631A1 (ja) Rna含有組成物
HK40128805A (en) Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof
HK40110483A (en) Conjugate of saponin, oligonucleotide and galnac
HK40110483B (en) Conjugate of saponin, oligonucleotide and galnac
JP2025514180A5 (cg-RX-API-DMAC10.html)
HK40129944A (zh) Galnac和皂苷的缀合物、包含所述缀合物和galnac-寡核苷酸缀合物的治疗性组合物